引用本文:陈文政综述,柳青峰,王燕庆审校.结直肠癌肝转移个体化综合性治疗的研究进展[J].大连医科大学学报,2016,38(1):97-100.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
结直肠癌肝转移个体化综合性治疗的研究进展
陈文政综述1, 柳青峰2, 王燕庆审校2
1.大连医科大学第二临床医学院,辽宁 大连 116027;2.辽宁省人民医院 普外科,辽宁 沈阳 110013
摘要:
结直肠癌是临床上常见的消化道恶性肿瘤,近年来其发病率逐渐上升。肝脏是结直肠癌最常见的转移部位,并且肝转移是结直肠癌患者死亡的主要原因。结直肠癌肝转移患者通过手术治疗、新辅助治疗、分子靶向治疗、肝动脉导管化疗栓塞治疗、射频消融治疗等个体化综合治疗后,疾病进展可得到控制,并可改善生活质量,延长生存时间。本文就结直肠癌伴肝转移的个体化综合性治疗最新进展进行综述。
关键词:  结直肠癌  肝转移  综合治疗
DOI:10.11724/jdmu.2016.01.24
分类号:R735.3
基金项目:
Research progress of individual and comprehensive therapy for colorectal carcinoma with liver metastases
CHEN Wen-zheng1, LIU Qing-feng2, WANG Yan-qing2
1.The Second Clinical Medical College of Dalian Medical University, Dalian 116027,China;2.Department of General Surgery, People′s Hospital of Liaoning Province, Shenyang 110013,China
Abstract:
Colorectal carcinoma is a common malignant tumor of the digestive system. Its incidence is gradually rising within recent years. Liver is the most common metastasis organ of colorectal carcinoma and liver metastasis is the major cause of mortality for colorectal cancer. Through surgery, neo-adjuvant therapy, molecular target therapy, intra -arterial hyperthermia chemoembolization, and radio frequency ablation, we can control the disease progression and improve the life quality of patients and prolong their survival time. Research progress of individual and comprehensive therapy for liver metastases from colorectal carcinoma is reviewed in this paper.
Key words:  colorectal carcinoma  liver metastasis  comprehensive therapy